March 21, 2026 Comment Surfactant therapy in severe infant bronchiolitis: evidence from the BESS trial Sailesh Kotecha ++++ +...

Epidemiology, ventilation, and outcomes of acute respiratory failure in immunocompromised patients from 103 intensive care units in 26 countries: a retrospective observational study Elie Azoulay, MD PhDa elie.azoulay@aphp.fr ∙ Colleen McEvoy, MDb ∙ Pedro Castro, MD PhDc ∙ Ali Ait Hssain, MDd,e,f ∙ Fabio Silvio Taccone, MD PhDg ∙ Sheila N Myatra, MDh ∙ et al. https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00046-9/fulltext?dgcid=hubspot_email_conferencealerts_isicem26&utm_campaign=conferencealerts&utm_medium=email&_hsenc=p2ANqtz-9QlNyhPFU86z2JDtgN2a2DBT6JALTsSo6ND0oaMQjeQIiwXSr4DQUOMTivy5OwGjqU3SvoxkELgkPEiPtblRGrxPyvtQ&_hsmi=409565470&utm_content=409565470&utm_source=hs_email Quantifying immune dysregulation in pneumonia and sepsis with a parsimonious machine-learning model: a multicohort analysis across care settings and reanalysis of a hydrocortisone randomised controlled trial Erik H A Michels, MDa e.h.michels@amsterdamumc.nl ∙ Prof Pierre-François Dequin, MDb ∙ Joe M Butler, PhDa ∙ Prof Antoine Guillon, MDb ∙ Bruno Evrard, MDc,d ∙ Fleur P Paling, MDe ∙ et al. https://www.thelancet.com/journals/lanonc/article/PIIS2213-2600(25)00429-1/abstract?dgcid=hubspot_email_conferencealerts_isicem26&utm_campaign=conferencealerts&utm_medium=email&_hsenc=p2ANqtz-8L5nV92-wtmTIHU1zcGast8l9c6BaFZr9MS4rQgufVxHG2g4V6ag7RD8iR20MMJfwAc20XivdY15d2WoNqxvyEVZupeA&_hsmi=409565470&utm_content=409565470&utm_source=hs_email Acute respiratory failure in immunocompromised adults: the case for personalised care strategies Carol L Hodgsona,b carol.hodgson@monash.edu ∙ Richard A Greendykc https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(26)00075-5/abstract?dgcid=hubspot_email_conferencealerts_isicem26&utm_campaign=conferencealerts&utm_medium=email&_hsenc=p2ANqtz--grsXeXZOPEjG5iFNW5AVM9G2VZlkyYoUpDJDYNpCiBdmH7WJ5BxR2Uzz9df-4lgBxZJoS_FzuUcnsJOJxbm2oc0Xf1A&_hsmi=409565470&utm_content=409565470&utm_source=hs_email The host response in sepsis: can it be quantified? Pratik Sinhaa p.sinha@wustl.edu ∙ Nuala J Meyer https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00465-5/abstract?dgcid=hubspot_email_conferencealerts_isicem26&utm_campaign=conferencealerts&utm_medium=email&_hsenc=p2ANqtz-9tuqjELn4dxNzUL-LITiCLMqvuTZ_ehY5VVtHT_6ZY4RvEU8GnJnP27O2Hiox5eIVSbOG5UNi2d_xgJEGltJ3BRH1Hag&_hsmi=409565470&utm_content=409565470&utm_source=hs_email March 21, 2026 Comment Surfactant therapy in severe infant bronchiolitis: evidence from the BESS trial Sailesh Kotecha https://www.thelancet.com/journals/lanres/onlinefirst